Spyre Therapeutics Inc.

11.73
-0.66 (-5.33%)
At close: Apr 08, 2025, 3:59 PM
11.99
2.24%
After-hours: Apr 08, 2025, 07:00 PM EDT

Spyre Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
n/a 886K 2.33M 18.74M n/a n/a 3.89M 5.21M 4.63M
n/a 964K 1.96M 2M 1.62M 901K n/a n/a n/a
n/a -78K 365K 16.74M -1.62M -901K 3.89M 5.21M 4.63M
-208.57M -242.3M -84.78M -65.65M -81.48M -80.33M -45.46M -27.68M -21.91M
21.31M 6.15M 837K 111K 593K 2.14M 1.17M 482K 244K
-207.97M -338.82M -83.95M -65.66M -80.89M -78.25M -44.35M -27.24M -21.7M
-208.02M -338.79M -83.81M -65.8M -80.89M -78.25M -44.35M -27.24M -21.7M
45.78M 39.95M 28.53M 27.32M 21.84M 14.83M 12.34M 9.82M 8.26M
162.79M 89.5M 58.58M 57.07M 59.64M 64.6M 36.72M 22.82M 18.14M
n/a 113.74M -7K -122K -5K n/a n/a n/a n/a
208.57M 243.19M 87.11M 84.39M 81.48M 79.43M 49.06M 32.63M 26.4M
n/a n/a n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a n/a
n/a 243.19M 87.11M 84.39M 81.48M 80.33M 49.35M 32.88M 26.53M
-51K -26K -136K 141K -593K n/a n/a n/a n/a
374.39M 7.34M 3.37M 2.63M 2.13M 1.28M 832.9K 605.13K 391.67K
374.39M 7.34M 3.37M 2.63M 2.13M 1.28M 832.9K 605.13K 391.67K
-0.56 -46.15 -24.86 -25.02 -37.89 -61.23 -53.25 -45.01 -55.4
-0.56 -46.15 -24.86 -25.02 -37.89 -61.23 -53.25 -45.01 -55.4
-208.57M -127.82M -83.21M -63.66M -79.27M -77.35M -45.17M -27.43M -21.77M
n/a -128.56M -84.78M -65.65M -80.89M -78.25M -45.46M -27.68M -21.91M
n/a 964K 1.96M 2M 1.62M 901K 293K 249K 132K